1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Hypercholerolemia: new trials by email Literature Review of Hypercholerolemia trials Research Report on Hypercholerolemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042) MK0653; ezetimibe / Duration of Treatment: 12 weeks, Comparator: simvastatin / Duration of Treatment: 12 weeks - Hypercholerolemia | Phase 3 | Completed | Organon and Co | 136 | 2002-12-01 | 2024-08-15 |
Duration of Therapy (1) · Ezetimibe (1)
Organon and Co (1)